Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. Review uri icon


MeSH Major

  • Arabs
  • Lymphoma


  • In the Middle East and North Africa (MENA) region, cancer has many epidemiologic and clinical features that are different from those in the rest of the world. Additionally, the region has a relatively young population and large disparities in the availability of resources at diagnostic and treatment levels. A critical need exists for regional guidelines on cancer care, including those for lymphoid malignancies. A panel of lymphoma experts from MENA reviewed the 2009 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Non-Hodgkin's Lymphoma and Hodgkin Lymphoma and suggested modifications for the region that were discussed with the United States NCCN Lymphoma Panels. This article presents the consensus recommendations.

publication date

  • July 2010



  • Review



  • eng

PubMed ID

  • 20697129

Additional Document Info

start page

  • S29

end page

  • 35


  • 8 Suppl 3